Themis Medicare share price is Up ▲ 10.57% on 20-Sep-2024

Themis Medicare share price is Up ▲ 10.57% on 20-Sep-2024. | 1.13m shares traded.
Its CMP is Rs 285.6 and MCap is approx : 2637 Crores.
The stock is up ▲ 4% in 7 days,
up ▲ 8.4% in 1 month
and up ▲ 31.3% in 2 months.
Please click image for Latest Daily data.
Themis Medicare results June 2024 (Standalone_YoY) Themis Medicare revenue elevated to 106 crores up 9% in June 2024 quarter, compared with 97 crores in June 2023. Themis Medicare Net profit is 19 crores up 46% in June 2024 quarter, compared with 13 crores in last year same quarter. Please click Image for Daily Data and Results of the stock.
* Data updated everyday at 7pm. Only Data. Not Buy or Sell advice.

Click Image for Data | Scroll down for Comments

About Themis Medicare :

Founded: 1969
Headquarters: India
Number of employees: 996 (2023)
Subsidiaries: Themis Medicare Singapore Pte Ltd., Artemis Biotech, Rx Themis Private Limited

Themis Medicare Limited is an Indian company that manufactures pharmaceutical products, especially active pharmaceutical ingredients (API) and formulation. The company was founded in 1969 and is located in Vapi, Gujarat. Themis Medicare has manufacturing facilities in Vapi and Hyderabad. The plant in Vapi produces intermediaries, bulk drugs, and tablet formulations for the anti tuberculosis segment and other therapeutic segments.

Themis Medicare’s products include:
E Mal 75mg Injection
E Mycin 250mg Tablet
E Mycin 500mg Tablet
Eldepryl 10mg Tablet
Eskimo 20mg Tablet
Floxaquin N 400mg Tablet
Floxaquin P 400mg Tablet
Gummy Cal Kids Tablet
Gummy Vita Kids Tablet

Themis Medicare’s subsidiaries include Artemis Biotech, Themis Medicare Singapore Pte Ltd, and Rx Themis Private Limited.
—————————————————-
* About company information is from various sources on the internet ( March 2024 ).
Please verify the official website of company for the latest updated information.
—————————————————-

Please visit